Webinar: the growing utilization of copay accumulator programs
Over the past four years, commercial health plans and pharmacy benefit managers have devised copay accumulator programs, which exclude the use of manufacturer-sponsored commercial copay assistance from a patient’s accrual of out-of-pocket (OOP) expenses throughout a plan benefit year. As the use of copay accumulators continues against pharmacy benefit drugs, commercial plans may explore new models targeting medical benefit products.
With large health plans pursuing accumulator models targeting medical benefit products, manufacturers offering copay assistance for those products will need to incorporate accumulator mitigation strategies into their program design.
View our on-demand webinar to learn:
- Copay accumulator and maximizer trends
- Operational solutions
- Impact on patients and copay programs
- Future landscape
- Manufacturer strategies for consideration
Listen to Corey Ford, Director, Reimbursement & Policy Insights for Xcenda and Dale Hanna, Director, Product Management for Lash Group, as they provide insights and strategies for manufacturers to consider in light of this new accumulator model.
Cencora.com is providing automated translations to assist in reading the website in languages other than English. For these translations, reasonable efforts have been made to provide an accurate translation, however, no automated translation is perfect nor is it intended to replace human translators. These translations are provided as a service to users of Cencora.com and are provided "as is." No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, or correctness of any of these translations made from English into any other language. Some content (such as images, videos, Flash, etc.) may not be accurately translated due to the limitations of the translation software.
Any discrepancies or differences created in translating this content from English into another language are not binding and have no legal effect for compliance, enforcement, or any other purpose. If any errors are identified, please contact us. If any questions arise related to the accuracy of the information contained in these translations, please refer to the English version of the page.